Drug Trial Radar · NCT06414954
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Last checked: Nov 19, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
84
Planned (sponsor's estimate)
Start
May 16, 2024
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- NMD Pharma A/SIndustry
- Sponsor type
- Industry
- First posted
- May 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 2 proof-of-concept, dose range finding study aims to evaluate the safety and efficacy of 3 dose levels of NMD670 vs placebo in adult patients with MG with antibodies against AChR or MuSK, administered twice a day (BID) for 21 days.
Conditions
- Myasthenia Gravis
- Myasthenia Gravis, MuSK
Interventions
NMD670Drug
Tablets taken twice a day for 21 days
PlaceboDrug
Tablets taken twice a day for 21 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline to day 21 in QMG total score for NMD670 vs placeboTime frame: Baseline to day 21
Locations
40 sites in 10 countries. Site status is shown where the registry gives one.
Profound Research LLC
Carlsbad, California · Withdrawn
University of California Irvine Medical Center
Irvine, California · Recruiting
University of Colorado Neuromuscular Division
Aurora, Colorado · Recruiting
SFM Clinical Research, LLC
Boca Raton, Florida · Recruiting
Neuromuscular Research Division | University of South Florida
Tampa, Florida · Recruiting
Augusta University, Neuroscience Center
Augusta, Georgia · Recruiting
NextGen Precision Health
Columbia, Missouri · Recruiting
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina · Recruiting
The Ohio State University
Columbus, Ohio · Recruiting
University of Oregon
Portland, Oregon · Recruiting
Semmes Murphey Clinic
Memphis, Tennessee · Withdrawn
UZ Leuven
Leuven, Belgium · Withdrawn
Aarhus University Hospital
Aarhus, Denmark · Recruiting
Rigshospitalet University of Copenhagen
Copenhagen, Denmark · Recruiting
Centre de référence des maladies neuromusculaires AOC-CHU de Bordeaux - Hôpital Pellegrin
Bordeaux, France · Recruiting
Centre de Référence des Maladies Neuromusculaires et de la SLA
Marseille, France · Recruiting
Centre Hospitalier Universitaire de Nantes - Hôtel Dieu Centre de Référence des Maladies Neuromusculaires Rares -
Nantes, France · Recruiting
CHU de Nice
Nice, France · Recruiting
Unité de Recherche Clinique NeuroSciences
Nice, France · Recruiting
JSC Curatio
Tbilisi, Georgia · Active not recruiting
LTD David Tatishvili Health Center
Tbilisi, Georgia · Active not recruiting
Ltd New Hospitals
Tbilisi, Georgia · Active not recruiting
ASST Papa Giovanni XXIII (Azienda Ospedaliera Papa Giovanni XXIII)
Bergamo, Italy · Recruiting
IRCCS Istituo delle Scienze neurologiche di Bologna, UOC Clinica neurologica Ospedale
Bologna, Italy · Recruiting
IRCCS Ospedale Policlinico San Martino
Genova, Italy · Recruiting
IRCCS Fondazione Istituto Neurologico Carlo Besta, Dipartimento di Ricerca e Sviluppo clinico
Milan, Italy · Recruiting
DIMER, IRCCS, Ospedale San Raffaele
Milan, Italy · Recruiting
Centro Sclerosi Multipla Napoli - AOU Vanvitelli
Naples, Italy · Recruiting
AOU Pisana
Pisa, Italy · Recruiting
Azienda Ospedaliera Sant'Andrea - Universita di Roma La Sapienza
Roma, Italy · Recruiting
Leiden Universitair Medisch Centrum (LUMC)
Leiden, Netherlands · Recruiting
Neurologia Śląska Centrum Medyczne
Katowice, Poland · Recruiting
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie sp.z o.o
Krakow, Poland · Recruiting
Centrum Medyczne Hope Clinic
Lublin, Poland · Recruiting
Galen Clinic
Lublin, Poland · Recruiting
NeuroCor Banaszkiewicz, Tomaszewski Lekarze Spółka Partnerska
Myślenice, Poland · Recruiting
Centrum Medyczne Neuro Protect
Warsaw, Poland · Recruiting
University Clinical Center of Serbia, Neurology Clinic
Belgrade, Serbia · Withdrawn
University Clinical Center Nis, Neurology Clinic
Niš, Serbia · Recruiting
Hospìtal Universitari Vall d'Hebrón
Barcelona, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.